828 related articles for article (PubMed ID: 15757531)
1. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.
Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J
Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217
[TBL] [Abstract][Full Text] [Related]
3. [Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma].
Lu ZQ; Wang YM; Cao YY; Zhang QJ; Zhang XH; Li YH; Wang HS; Xie HL; Jiao BH; Zhang JH
Ai Zheng; 2007 May; 26(5):463-8. PubMed ID: 17672933
[TBL] [Abstract][Full Text] [Related]
4. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
[TBL] [Abstract][Full Text] [Related]
5. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma.
Zhang J; Jin X; Fang S; Li Y; Wang R; Guo W; Wang N; Wang Y; Wen D; Wei L; Kuang G; Dong Z
Carcinogenesis; 2004 Dec; 25(12):2519-24. PubMed ID: 15319302
[TBL] [Abstract][Full Text] [Related]
6. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315
[TBL] [Abstract][Full Text] [Related]
7. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
Zhang J; Jin X; Fang S; Wang R; Li Y; Wang N; Guo W; Wang Y; Wen D; Wei L; Dong Z; Kuang G
Carcinogenesis; 2005 Oct; 26(10):1748-53. PubMed ID: 15930031
[TBL] [Abstract][Full Text] [Related]
8. [Association of single nucleotide polymorphism in matrix metalloproteinases promoter with susceptibility to ovarian cancer].
Li Y; Wang Y; Kang S; Zhang JH; Guo W; Wang N; Jin X; Fang SM
Zhonghua Fu Chan Ke Za Zhi; 2005 Jul; 40(7):472-5. PubMed ID: 16080875
[TBL] [Abstract][Full Text] [Related]
9. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility.
Ghilardi G; Biondi ML; Caputo M; Leviti S; DeMonti M; Guagnellini E; Scorza R
Clin Cancer Res; 2002 Dec; 8(12):3820-3. PubMed ID: 12473595
[TBL] [Abstract][Full Text] [Related]
10. [A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].
Lou Y; Fang CQ; Li JH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):59-62. PubMed ID: 17285546
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
[TBL] [Abstract][Full Text] [Related]
12. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
Krippl P; Langsenlehner U; Renner W; Yazdani-Biuki B; Köppel H; Leithner A; Wascher TC; Paulweber B; Samonigg H
Clin Cancer Res; 2004 May; 10(10):3518-20. PubMed ID: 15161710
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhang XF; Wang YM; Wang R; Wei LZ; Li Y; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 May; 24(5):513-9. PubMed ID: 15890089
[TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome.
Liu PY; Li YH; Chan SH; Lin LJ; Wu HL; Shi GY; Chen JH
Am J Cardiol; 2006 Oct; 98(8):1012-7. PubMed ID: 17027562
[TBL] [Abstract][Full Text] [Related]
15. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
Li Y; Jin X; Kang S; Wang Y; Du H; Zhang J; Guo W; Wang N; Fang S
Gynecol Oncol; 2006 Apr; 101(1):92-6. PubMed ID: 16278009
[TBL] [Abstract][Full Text] [Related]
17. The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer.
Szyllo K; Smolarz B; Romanowicz-Makowska H; Niewiadomski M; Kozlowska E; Kulig A
J Exp Clin Cancer Res; 2002 Sep; 21(3):357-61. PubMed ID: 12385578
[TBL] [Abstract][Full Text] [Related]
18. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
Zhu Y; Spitz MR; Lei L; Mills GB; Wu X
Cancer Res; 2001 Nov; 61(21):7825-9. PubMed ID: 11691799
[TBL] [Abstract][Full Text] [Related]
19. PCR analysis of matrix metalloproteinase 3 (MMP-3) gene promoter polymorphism in ovarian cancer.
Smolarz B; Szyłło K; Romanowicz-Makowska H; Niewiadomski M; Kozłowska E; Kulig A
Pol J Pathol; 2003; 54(4):233-8. PubMed ID: 14998290
[TBL] [Abstract][Full Text] [Related]
20. Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer.
Vairaktaris E; Yapijakis C; Vasiliou S; Derka S; Nkenke E; Serefoglou Z; Vorris E; Vylliotis A; Ragos V; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(6B):4095-100. PubMed ID: 18225577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]